Dr. Shukair received his MD from Damascus University, Syria. He completed General Psychiatry Training Program with psychoanalytic training at the University of Texas Southwestern in Dallas. Dr. Shukair completed a Child and Adolescents Psychiatry training in Children’s Hospital of Boston, Harvard University. Dr. Shukair‘s current work focuses on attachment, ADHD and the interaction between executive functions and mental wellness.
Dr. Michael Cooper is a psychiatrist trained in both psychotherapy and psychopharmacology. He completed his M.D. at Albert Einstein School of Medicine, his residency at NYU Langone Hospital and was faculty member at NYU School of Medicine, where he participated in novel clinical trials for psilocybin-assisted psychopharmacologic therapy for alcoholism. Dr. Cooper is strengthening Valera Health’s quality improvement program and new clinical trials program.
Recognizing that every patient is unique, possessing their own set of strengths and facing their own distinct set of challenges, my goal is to create an individualized treatment plan, customized for each client. Together we will identify innate talents, opportunities for growth, as well as identify the best pharmacologic treatment to support each person’s needs and goals.
Jessica is a psychiatrist who spent the last several years working at various nonprofit community-based organizations in NYC. She uses a recovery-oriented approach and a person-centered framework in her practice of psychiatry. And she believes in combining psychopharmacology and psychotherapy to create multidimensional plans of care.
Larry Ozowara is a psychiatrist who specializes in the collaboration between inpatient and outpatient care. He attended Stanford Medical School, completed a residency in adult psychiatry at Columbia University and is a former Assistant Professor at NYU School of Medicine where he supervised and trained medical students, residents and fellows in psychiatry. He has extensive experience in working with patients with schizophrenia, bipolar disorder and patients with serious and persistent mental illness. Dr. Ozowara directs Valera’s psychiatry program and HEDIS improvement program for healthplans and hospitals.
He was the former CMO at a Merck subsidiary focused on commercializing digital solutions. Prior to Merck, Tom was part of the team that developed the Affordable Care Act on the House Committee on Ways and Means and worked on the development of a national framework for the use of electronic health records as Medical Director at the Office of the National Coordinator for HIT, HHS. He started his career as Chief Medical Officer working at Charles B. Wang, a Federally Qualified Health Center serving the immigrant Asian population in NYC and served on the Board of Health for NYC. He currently serves on several boards including BCBS Kansas City.